
|Articles|September 1, 2001
Ceramide-dominant barrier repair moisturizer improves AD
Washington - A ceramide-dominant barrier repair moisturizer (TriCeram) is a valuable adjuvant in the treatment of atopic dermatitis, according to the results of a study presented by University of California, San Francisco dermatology researchers at the annual meeting of the Society for Investigative Dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Christopher Bunick, MD, PhD, on Expanding Targets in Inflammatory Skin Disease
2
Mona Shahriari, MD, FAAD, on OX40-Targeted Therapy in AD
3
When Innovation Meets Insurance Barriers With Lisa Swanson, MD
4
GLP-1s and Skin Health: Clinical Pearls From Gold and Lal
5










